Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Thursday’s Top Trending Tickers: MSFT, VOD, LB, BMRN, GLW

Page 1 of 2

The U.S stock market is green across the board as positive reigns ahead of crucial jobs data to be announced tomorrow. Some of the stocks that investors are monitoring closely today include BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), L Brands Inc (NYSE:LB), Corning Incorporated (NYSE:GLW), Microsoft Corporation (NASDAQ:MSFT), and Vodafone Group Plc (ADR) (NASDAQ:VOD). Let’s find out why investors’ interest has been piqued and see what the collection of elite hedge funds in our system think of these companies.

Hedge funds and other institutional investors allocate significant resources while making their bets and their long-term focus makes them the perfect investors to emulate. This is supported by our research, which determined that following the small-cap stocks that hedge funds are collectively bullish on can help a smaller investor beat the S&P 500 by around 95 basis points per month (see more details here).

Microsoft Corporation (NASDAQ:MSFT), Microsoft corporate offices, people, sign, building, logo

Northfoto / Shutterstock.com

Roche Considering Acquisition of BioMarin Pharmaceutical

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares have skyrocketed by just under 8% this morning after a report published on Betaville claimed that Swiss healthcare giant Roche Holding AG is considering the acquisition of the California-based rare disease drug company. The source said that Roche was “quite close” to making a formal bid to acquire Biomarin, but that the Brexit referendum’s aftermath temporarily tarnished the plan. The report claimed that Roche is expected to offer around $130-to-$150 per share to BioMarin should it proceed with its takeover plans.

A total of 44 hedge funds in our database were shareholders of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) at the end of the first quarter. Julian Baker and Felix Baker’s Baker Bros. Advisors had amassed about 4.81 million shares of the company as of the end of March.

Follow Biomarin Pharmaceutical Inc (NASDAQ:BMRN)
Trade (NASDAQ:BMRN) Now!

L Brands Sales Rose in June

L Brands Inc (NYSE:LB) is in the spotlight this morning after the company reported a rise in same-store sales for the month of June. The Ohio-based personal care and beauty products company reported a 6% jump in comparable-store sales, dwarfing the consensus estimate of a 2.1% rise. However, the company expects sales to decline in July, which has put a damper on the strong June results. Shares of L Brands have slipped by 0.86% in morning trading. As of March 31, Alex Snow’s Lansdowne Partners owned around 8.59 million shares of L Brands Inc (NYSE:LB).

Follow L Brands Inc. (NYSE:LB)
Trade (NYSE:LB) Now!

On the next page we’ll discuss the movement witnessed in the shares of Corning, Microsoft and Vodafone this morning.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!